Furthermore, we also investigated FTO-mediated m6A RNA demethylation to understand the mechanisms contributing to the pharmacological effects of Rb1 against NETs-induced endothelial activation in atherosclerosis. This evidence concerns the gene FTO and atherosclerosis.